To confirm the safety and efficacy of an implantable cardiac monitor (ICM) in patients who require long term cardiac monitoring due to suspected cardiac arrhythmia or unexplained syncope.
Cardiovascular disease & care
|Eligibility criteria|| |
To be considered for the study you must meet the following criteria:
|Study details|| |
Your participation in this study would be for approximately 12 months.
If you meet all eligibility criteria, you will be required to go into hospital for a day to have the device implanted.
Participants implanted with an ICM will have follow-up assessments prior to hospital discharge and at clinic visits at 10 days to 4 weeks, 3 months & 12 months post implant. Procedures conducted at the follow-up visits may include answering questions regarding the wearing comfort of the device, device interrogation and programming, check of the insertion location and device migration and device deficiency and adverse events assessments. In addition, after the first follow up visit, you will be required to wear an external Holter monitor for 48 hours to verify the accuracy and arrhythmia detection performance of the ICM.
You will be reimbursed for travel and study expenses.
Sign up to this clinical trial here.
Auchenflower QLD, Bundaberg QLD, Doncaster East VIC